The Gross Margin of Neogenomics Inc (NEO) is 43.92%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-12-31 | 43.92% |
| 2023-12-31 | 41.34% |
| 2022-12-31 | 36.86% |
| 2021-12-31 | 38.61% |
| 2020-12-31 | 41.81% |
| 2019-12-31 | 48.14% |
| 2018-12-31 | 45.97% |
| 2017-12-31 | 42.45% |
| 2016-12-31 | 42.32% |
| 2015-12-31 | 43.89% |